Fact sheet: Invesco Global Health Care

Fund information

Fund name
Invesco Global Health Care A USD
Fund company manager
Invesco Global Asset Mgmt Ltd
Fund type
SIB
Fund manager
Mike Yellen
since 01/10/2004
Fund objective
The Fund aims to achieve long term capital growth by investing in shares of healthcare companies throughout the world. For the full objectives and investment policy please consult the current prospectus.
Benchmark
MSCI World Health Care
Investment style
Growth
Investment method
Shares

Performance snapshot

Quick stats

1 Year return

2.18 %

1 Year rank in sector

18/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 483.8 m

FE Risk score

164

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    81.5%
  • Switzerland
    4.8%
  • France
    2.6%
  • Japan
    2.6%
  • Germany
    2.5%
  • Biotechnology/Medical
    45.9%
  • Pharmaceuticals
    27.8%
  • Health Care
    15.9%
  • Healthcare & Medical Products
    7.3%
  • Money Market
    1.5%
  • US Equities
    81.5%
  • Swiss Equities
    4.8%
  • French Equities
    2.6%
  • Japanese Equities
    2.6%
  • German Equities
    2.5%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund-3.22 %3.04 %2.18 %4.72 %64.7 %
Sector-2.14 %3.95 %6.57 %24.27 %99.62 %
Rank within sector22 / 3019 / 2918 / 2924 / 2622 / 23
Quartile th3 rd3 rd3 rd4 th4 th

Calendar performance

YTD-20172016201520142013
Fund10.89 %-13.51 %1.02 %19.31 %37.53 %
Sector12.56 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector18 / 2918 / 2925 / 2722 / 2412 / 23
Quartile th3 rd3 rd4 th4 th3 rd

Risk statistics

Alpha-5.2
Beta1.02
Sharpe-0
Volatility16.47
Tracking error4.82
Information ratio-1.07
R-Squared0.91

Price movement

52 week high131.29
52 week low106.49
Current bid price0
Current offer price0
Current mid price124.89

Holdings by region

  • 81.5% USA
  • 4.8% Switzerland
  • 2.6% France
  • 2.6% Japan
  • 2.5% Germany
  • 1.5% Money Market
  • 1.5% Others
  • 1.1% Netherlands
  • 1% UK
  • 0.9% Brazil

Holdings by sector

  • 45.9% Biotechnology/Medical
  • 27.8% Pharmaceuticals
  • 15.9% Health Care
  • 7.3% Healthcare & Medical Products
  • 1.5% Money Market
  • 1.1% Conglomerates
  • 0.5% Food & Drug Retailers

Holdings by asset type

  • 81.5% US Equities
  • 4.8% Swiss Equities
  • 2.6% French Equities
  • 2.6% Japanese Equities
  • 2.5% German Equities
  • 1.5% International Equities
  • 1.5% Money Market
  • 1.1% Dutch Equities
  • 1% UK Equities
  • 0.9% Brazilian Equities

Individual holdings

  • 3.6% CELGENE CORP
  • 3.6% SHIRE PLC
  • 3.4% ALEXION PHARMACEUTICALS INC
  • 3% BIOMARIN PHARMACEUTICAL
  • 2.9% THERMO FISHER SCIENTIFIC INC
  • 2.2% VERTEX PHARMACEUTICAL
  • 1.7% AETNA INC
  • 1.7% INCYTE CORP
  • 1.5% WRIGHT MEDICAL GROUP NV
  • 1.4% CLOVIS ONCOLOGY INC